OP0027 Abnormal B Cell Activation through Cellular Metabolic Reprogramming and Its Relevance To The Pathogenesis of SLE

免疫球蛋白D B细胞 TLR9型 免疫学 生发中心 细胞分化 BCL6公司 生物 分子生物学 医学 抗体 DNA甲基化 基因表达 生物化学 基因
作者
Masataka Torigoe,S. Iwata,K. Sakata,Shingo Nakayamada,Yoshiki Tanaka
出处
期刊:Annals of the Rheumatic Diseases [BMJ]
卷期号:75 (Suppl 2): 63.1-63
标识
DOI:10.1136/annrheumdis-2016-eular.2223
摘要

Background

B cells play a pivotal role in autoimmune diseases. In SLE, IFN signature is displayed and aberrant function of Toll-like receptors (TLR) for recognizing nucleic acids contributes to its pathology. Peripheral plasmablasts increase in active SLE, but the relevance of cellular metabolisms to B cell differentiation to plasmablasts remains unclear.

Objectives

To examine the mechanism by which cellular metabolic reprogramming regulates human B cell differentiation in vitro, and its involvement in pathological processes of SLE.

Methods

Human B cells were obtained from peripheral blood of healthy donors (HDs), and separated into 3 subsets; naïve (IgD+CD27), IgM memory (IgD+CD27+) and class-switched (CS) memory B cells (IgDCD27+). Each subset was cultured with CpG DNA (ligand of TLR9) and/or IFN-α. Plasmablast (CD27hi) differentiation, immunoglobulin (IgM, IgG), and cytokine production (IL-6, IL-10), and cellular metabolism (mTORC1, AMPK, glycolysis) were assessed.

Results

When IgM memory B cells and CS memory B cells were stimulated with CpG, robust production of IL-6 and IL-10 as well as differentiation to plasmablasts were induced. The gene expression of IRF4, XBP1 and PRDM1 was increased by CpG, whereas that of BACH2 and BCL6 was decreased. These responses were amplified by IFN-α, which was abrogated by anti-IFNAR2 Abs. A JAK inhibitor tofacitinib did not attenuate CpG-induced B cell differentiation to plasmablasts, indicating that JAK-mediated signaling by autocrine IL-6 and IL-10 was not relevant to the differentiation. Next, we analyzed cellular metabolic reprogramming during B cell differentiation, which was recently highlighted for its involvement in T cell differentiation. CpG stimulation strongly induced p-mTORC1 and lactic acid production, indicating that there is a metabolic shift to glycolysis in B cells. IFN-α further augmented this pathway. However, a glycolysis inhibitor, 2-deoxy-D-glucose and an mTORC1 inhibitor, rapamycin significantly abrogated lactic acid production, cytokine production and plasmablast differentiation of B cells in a dose-dependent manner. AMPK activators, metformin and AICAR, which are known to indirectly inhibit mTORC1, not only suppressed plasmablast differentiation but also induced IgDCD27 memory B cells. These results indicate that CpG and IFN-α shifted mTORC1/AMPK balance toward mTORC1 activation and glycolysis, leading to plasmablast differentiation. Interestingly, p-mTORC1 was significantly enhanced in B cells of SLE patients, compared to HDs (p<0.05), and it positively correlated with percentage of peripheral plasmablasts (r =0.709, p<0.01) and SLEDAI score (r =0.453, p<0.05), and negatively correlated with CH50 (r = -0.452, p<0.05).

Conclusions

CpG and IFN-α shifted mTORC1/AMPK balance toward mTORC1 activation and glycolysis, resulting in plasmablast differentiation, especially in memory B cells. The metabolic shift to anabolism supplied sufficient proteins and nucleic acids for rapid cell proliferation, permitting efficient differentiation to plasmablasts. Abnormal B cell activation through cellular metabolic reprogramming could contribute to SLE pathology. Thus, we first propose the disturbance of “immunometabolism” in B cells, and the regulation of B cell metabolism can provide a new therapeutic strategy against SLE.

Disclosure of Interest

M. Torigoe: None declared, S. Iwata: None declared, K. Sakata Employee of: Mitsubishi Tanabe Pharma, S. Nakayamada: None declared, Y. Tanaka Grant/research support from: Mitsubishi-Tanabe, Takeda, Chugai, Astellas, Eisai, Taisho-Toyama, Kyowa-Kirin, Abbvie, Bristol-Myers, Consultant for: Abbvie, Daiichi-Sankyo, Chugai, Takeda, Mitsubishi-Tanabe, Bristol-Myers, Astellas, Eisai, Janssen, Pfizer, Asahi-kasei, Eli Lilly, GlaxoSmithKline, UCB, Teijin, MSD, Santen, Speakers bureau: Abbvie, Daiichi-Sankyo, Chugai, Takeda, Mitsubishi-Tanabe, Bristol-Myers, Astellas, Eisai, Janssen, Pfizer, Asahi-kasei, Eli Lilly, GlaxoSmithKline, UCB, Teijin, MSD, Santen
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
上官若男应助chiweiyoung采纳,获得10
刚刚
桐桐应助秦pale采纳,获得10
1秒前
DrY发布了新的文献求助10
2秒前
八百标兵完成签到,获得积分10
2秒前
akmdh完成签到,获得积分10
3秒前
冯先森ya发布了新的文献求助10
5秒前
量子星尘发布了新的文献求助10
6秒前
6秒前
Jonathan完成签到,获得积分10
10秒前
wsj发布了新的文献求助10
11秒前
12秒前
整齐小松鼠应助wsj采纳,获得10
16秒前
16秒前
17秒前
17秒前
20秒前
20秒前
20秒前
21秒前
Owen应助超速也文章采纳,获得10
22秒前
张雯思发布了新的文献求助10
24秒前
清爽尔安发布了新的文献求助10
24秒前
25秒前
孙燕应助幸福大白采纳,获得30
25秒前
香香应助研友_Zzrx6Z采纳,获得10
25秒前
27秒前
28秒前
28秒前
从容的柜子完成签到 ,获得积分10
29秒前
29秒前
木可发布了新的文献求助10
30秒前
清爽尔安完成签到,获得积分10
31秒前
Komorebi完成签到 ,获得积分10
31秒前
qqq发布了新的文献求助10
31秒前
所所应助独特乘云采纳,获得10
32秒前
33秒前
34秒前
小蘑菇应助发疯的草莓采纳,获得10
35秒前
小绵羊发布了新的文献求助10
36秒前
八卦巧克力完成签到,获得积分10
36秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
‘Unruly’ Children: Historical Fieldnotes and Learning Morality in a Taiwan Village (New Departures in Anthropology) 400
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3989406
求助须知:如何正确求助?哪些是违规求助? 3531522
关于积分的说明 11254187
捐赠科研通 3270174
什么是DOI,文献DOI怎么找? 1804901
邀请新用户注册赠送积分活动 882105
科研通“疑难数据库(出版商)”最低求助积分说明 809174